Cardiovascular Systems Inc Annual Cost of Revenue in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Cardiovascular Systems Inc quarterly/annual Cost of Revenue history and growth rate from 2017 to 2022.
  • Cardiovascular Systems Inc Cost of Revenue for the quarter ending December 31, 2022 was $18.5M, a 2.15% increase year-over-year.
  • Cardiovascular Systems Inc Cost of Revenue for the twelve months ending December 31, 2022 was $66.2M, a 1.21% decline year-over-year.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2022 was $63.4M, a 3.78% increase from 2021.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2021 was $61.1M, a 25.4% increase from 2020.
  • Cardiovascular Systems Inc annual Cost of Revenue for 2020 was $48.8M, a 2.26% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.